BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 26706352)

  • 21. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
    Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
    Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
    Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG
    Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analogue-based design, synthesis and biological evaluation of 3-substituted-(methylenehydrazono)indolin-2-ones as anticancer agents.
    Dweedar HE; Mahrous H; Ibrahim HS; Abdel-Aziz HA
    Eur J Med Chem; 2014 May; 78():275-80. PubMed ID: 24686014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies.
    El-Azab AS; Al-Dhfyan A; Abdel-Aziz AA; Abou-Zeid LA; Alkahtani HM; Al-Obaid AM; Al-Gendy MA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):935-944. PubMed ID: 28718672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acylhydrazone derivatives as potential anticancer agents: Synthesis, bio-evaluation and mechanism of action.
    Yu X; Shi L; Ke S
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5772-6. PubMed ID: 26546214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives.
    Teng YO; Zhao HY; Wang J; Liu H; Gao ML; Zhou Y; Han KL; Fan ZC; Zhang YM; Sun H; Yu P
    Eur J Med Chem; 2016 Apr; 112():145-156. PubMed ID: 26890120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary in vitro evaluation of the anti-proliferative activity of guanylhydrazone derivatives.
    França PH; Da Silva-Júnior EF; Aquino PG; Santana AE; Ferro JN; De Oliveira Barreto E; Do Ó Pessoa C; Meira AS; De Aquino TM; Alexandre-Moreira MS; Schmitt M; De Araújo-Júnior JX
    Acta Pharm; 2016 Mar; 66(1):129-37. PubMed ID: 26959549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of thieno[3,2-d]pyrimidine derivatives containing aroyl hydrazone or aryl hydrazide moieties for PI3K and mTOR dual inhibition.
    Han Y; Tian Y; Wang R; Fu S; Jiang J; Dong J; Qin M; Hou Y; Zhao Y
    Bioorg Chem; 2020 Nov; 104():104197. PubMed ID: 32927132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents.
    Maddela S; Makula A; Jayarambabu N
    Anticancer Agents Med Chem; 2017; 17(3):456-463. PubMed ID: 27173964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isatin derivatives with activity against apoptosis-resistant cancer cells.
    Evdokimov NM; Magedov IV; McBrayer D; Kornienko A
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1558-1560. PubMed ID: 26883150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of isatin/triazole conjugates that induce apoptosis and inhibit migration of MGC-803 cells.
    Yu B; Wang SQ; Qi PP; Yang DX; Tang K; Liu HM
    Eur J Med Chem; 2016 Nov; 124():350-360. PubMed ID: 27597411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and apoptosis inducing studies of triazole linked 3-benzylidene isatin derivatives.
    Nagarsenkar A; Guntuku L; Guggilapu SD; K DB; Gannoju S; Naidu VGM; Bathini NB
    Eur J Med Chem; 2016 Nov; 124():782-793. PubMed ID: 27639369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study.
    Abdel-Aziz AA; El-Azab AS; AlSaif NA; Obaidullah AJ; Al-Obaid AM; Al-Suwaidan IA
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1521-1539. PubMed ID: 34266349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of novel benzylidene analogues of betulinic acid as potent cytotoxic agents.
    Gupta N; Rath SK; Singh J; Qayum A; Singh S; Sangwan PL
    Eur J Med Chem; 2017 Jul; 135():517-530. PubMed ID: 28500966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel pyrazolopyrimidines: Synthesis, in vitro cytotoxic activity and mechanistic investigation.
    Hassan GS; Abdel Rahman DE; Nissan YM; Abdelmajeed EA; Abdelghany TM
    Eur J Med Chem; 2017 Sep; 138():565-576. PubMed ID: 28704759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Novel Bis(indolyl)-hydrazide-Hydrazone Derivatives as Potent Microtubule-Targeting Cytotoxic Agents against A549 Lung Cancer Cells.
    Das Mukherjee D; Kumar NM; Tantak MP; Das A; Ganguli A; Datta S; Kumar D; Chakrabarti G
    Biochemistry; 2016 May; 55(21):3020-35. PubMed ID: 27110637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl)isatin derivatives as anticancer agents.
    Han K; Zhou Y; Liu F; Guo Q; Wang P; Yang Y; Song B; Liu W; Yao Q; Teng Y; Yu P
    Bioorg Med Chem Lett; 2014 Jan; 24(2):591-4. PubMed ID: 24360564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents.
    Yousef MA; Ali AM; El-Sayed WM; Qayed WS; Farag HHA; Aboul-Fadl T
    Bioorg Chem; 2020 Dec; 105():104366. PubMed ID: 33212312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.